camoteskimab

GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

Home
Ligands
camoteskimab

GtoPdb Ligand ID: 13187

Compound class: Antibody

Comment: Camoteskimab (Apollo Therapeutics) is a fully human IgG1 monoclonal antibody that targets the proinflammatory cytokine interleukin-18 (IL-18). It has anti-inflammatory actions for application in autoinflammatory diseases.

Summary
Biological activity
Clinical data
References
Immunopharmacology

References
1. FDA. Camoteskimab. Accessed on 26/02/2024. Modified on 26/02/2024. fda.gov, https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=961623
2. Galozzi P, Bindoli S, Doria A, Sfriso P. (2022) Progress in Biological Therapies for Adult-Onset Still's Disease. Biologics, 16: 21-34. [PMID:35481241]

References

1. FDA.
Camoteskimab.
Accessed on 26/02/2024. Modified on 26/02/2024. fda.gov, https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=961623

2. Galozzi P, Bindoli S, Doria A, Sfriso P. (2022)
Progress in Biological Therapies for Adult-Onset Still's Disease.
Biologics, 16: 21-34. [PMID:35481241]